Home > Archive > 2017 > 3

Volume 36, Number 3, pages 7-9

Commentary: Application of the AACE 2017 Lipid Guidelines to Diabetes

Kathleen Wyne, M.D., Ph.D.

The updated American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease were published in early 2017. Changes in this clinical practice guideline included the introduction of a new category of “extreme risk” with a low-density lipoprotein cholesterol (LDL-C) target of <55 mg/dl and an expanded discussion of lipid management in people with diabetes.

Complications and comorbiditiesCardiovascular diseaseDyslipidemia